Potential use of ubiquinol and d-ribose in patients with heart failure with preserved ejection fraction.

ABSTRACT: •Manuscript Highlights.•HFpEF is associated with reduced ATP production in the myocardium.•Ubiquinol and d-ribose both contribute to the generation of myocardial ATP.•Both ubiquinol and d-ribose are being studied as supplemental treatments for patients with HFpEF.

SUBMITTER: Pierce JD 

PROVIDER: S-EPMC7251495 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature